A dual catalytic functionalized hollow mesoporous silica-based nanocarrier coated with bacteria-derived exopolysaccharides for targeted delivery of irinotecan to colorectal cancer cells
Authors:
- 4 January 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 259, 129179
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Montmorillonite–alginate nanocomposite as a drug delivery system – incorporation and in vitro release of irinotecanInternational Journal of Pharmaceutics, 2014
- Assembled Microcapsules by Doxorubicin and Polysaccharide as High Effective Anticancer Drug CarriersAdvanced Healthcare Materials, 2013
- Limitations and niches of the active targeting approach for nanoparticle drug deliveryEuropean Journal of Nanomedicine, 2012
- Structural modification of DNA—a therapeutic option in SLE?Nature Reviews Rheumatology, 2011
- Advances in bacterial exopolysaccharides: from production to biotechnological applicationsTrends in Biotechnology, 2011
- On the Hysteresis Loop of Argon Adsorption in Cylindrical PoresThe Journal of Physical Chemistry C, 2011
- Preparation of monodispersed silica particles coated with ceria and control of coating thickness using sol-type precursorColloids and Surfaces A: Physicochemical and Engineering Aspects, 2010
- Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching StrategyACS Nano, 2009
- Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectivesBiomedical Chromatography, 2009
- Synthesis of CeO2-coated SiO2 nanoparticle and dispersion stability of its suspensionMaterials Chemistry and Physics, 2008